미국 - 영어 - NLM (National Library of Medicine)

baxter healthcare corporation - anhydrous dextrose (unii: 5sl0g7r0ok) (anhydrous dextrose - unii:5sl0g7r0ok) - anhydrous dextrose 13.6 g in 1000 ml

아르메니아 - 영어 - Դեղերի և բժշկական տեխնոլոգիաների փորձագիտական կենտրոնի գործունեության Հայաստանի Հանրապետությունում

teva czech industries s.r.o. - butamirate (butamirate citrate), guaifenesin - tablets - 4mg+100mg

아르메니아 - 영어 - Դեղերի և բժշկական տեխնոլոգիաների փորձագիտական կենտրոնի գործունեության Հայաստանի Հանրապետությունում

teva operations poland sp. z o.o - guaifenesin, butamirate (butamirate citrate) - tablets - 100mg+4mg

탄자니아 - 영어 - Tanzania Medicinces & Medical Devices Authority

medopharm, india - magnesium trisilicate bp , dried aluminium hydroxide gel bp - tablets - magnesium trisilicate 250 mg, dried aluminium hydroxide gel 120 mg

영국 - 영어 - MHRA (Medicines & Healthcare Products Regulatory Agency)

a a h pharmaceuticals ltd - magnesium sulfate dried; chloroform; magnesium oxide light; sodium hydroxide - oral suspension - 47.5mg/1ml ; 3microlitre/1ml ; 52.5mg/1ml ; 15mg/1ml

영국 - 영어 - MHRA (Medicines & Healthcare Products Regulatory Agency)

the boots company plc - magnesium sulfate dried; chloroform; magnesium oxide light; sodium hydroxide - oral suspension - 47.5mg/1ml ; 3microlitre/1ml ; 52.5mg/1ml ; 15mg/1ml

영국 - 영어 - MHRA (Medicines & Healthcare Products Regulatory Agency)

j m loveridge ltd - magnesium sulfate dried; chloroform; magnesium oxide light; sodium hydroxide - oral suspension - 47.5mg/1ml ; 3microlitre/1ml ; 52.5mg/1ml ; 15mg/1ml

영국 - 영어 - MHRA (Medicines & Healthcare Products Regulatory Agency)

thornton & ross ltd - magnesium sulfate dried; chloroform; magnesium oxide light; sodium hydroxide - oral suspension - 47.5mg/1ml ; 3microlitre/1ml ; 52.5mg/1ml ; 15mg/1ml

영국 - 영어 - MHRA (Medicines & Healthcare Products Regulatory Agency)

alliance healthcare (distribution) ltd - magnesium sulfate dried; chloroform; magnesium oxide light; sodium hydroxide - oral suspension - 47.5mg/1ml ; 3microlitre/1ml ; 52.5mg/1ml ; 15mg/1ml

미국 - 영어 - NLM (National Library of Medicine)

preferred pharmaceuticals, inc - sulfasalazine (unii: 3xc8guz6cb) (sulfasalazine - unii:3xc8guz6cb) - sulfasalazine 500 mg - sulfasalazine tablets are indicated: sulfasalazine tablets are contraindicated in: patients with intestinal or urinary obstruction, patients with porphyria as sulfonamides have been reported to precipitate an acute attack, patients hypersensitive to sulfasalazine, its metabolites, sulfonamides or salicylates. none reported.